4.6 Article

In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2

Gajendra Kumar Azad

Summary: The study identified 107 mutations in the N-protein of SARS-CoV-2, with 45% of mutations occurring in intrinsically disordered regions. These mutations may significantly alter the stability and dynamics of the N-protein, affecting its functions such as interaction with RNA, oligomerization, and signaling events.

PEERJ (2021)

Article Infectious Diseases

Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA

Ute Eberle et al.

Summary: In order to tackle the COVID-19 pandemic, there is a significant demand for fast and reliable diagnostic assays for detecting SARS-CoV-2. Laboratory experiences showed that different commercially available real-time RT-PCR assays varied considerably in performance and validation, calling for mandatory validation procedures before routine use.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Letter Infectious Diseases

Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B1.1.7 lineage

Konstantina Kontogianni et al.

JOURNAL OF INFECTION (2021)

Article Biochemistry & Molecular Biology

Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants

Charlie Laffeber et al.

Summary: Different mutations in new variants of SARS-CoV-2 have varying effects on receptor binding affinity, viral transmission, and immune evasion, highlighting the importance of global viral genome surveillance and functional characterization.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Infectious Diseases

Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study

Victor M. Corman et al.

Summary: This study compared the analytical sensitivity and specificity of seven commercially available antigen point-of-care test devices, showing that most devices have sensitivity overlapping with SARS-CoV-2 viral loads typically observed during the first week of symptoms, marking the infectious period in most patients. Antigen point-of-care tests with detection limits approximating virus concentrations at which patients are infectious may streamline decision-making in healthcare and public health.

LANCET MICROBE (2021)